MmCSM-AB: Guiding rational antibody engineering through multiple point mutations

Abstract

While antibodies are becoming an increasingly important therapeutic class, especially in personalized medicine, their development and optimization has been largely through experimental exploration. While there have been many efforts to develop computational tools to guide rational antibody engineering, most approaches are of limited accuracy when applied to antibody design, and have largely been limited to analysing a single point mutation at a time. To overcome this gap, we have curated a dataset of 242 experimentally determined changes in binding affinity upon multiple point mutations in antibodytarget complexes (89 increasing and 153 decreasing binding affinity). Here, we have shown that ..